Dr. Richard Horowitz, the medical director of the Hudson Valley Healing Arts Center in Hyde Park, NY, will reflect upon his experiences in treating chronic Lyme disease patients. In this talk, Dr Horowitz will discuss two of his brand new scientific studies with broad implications for the diagnosis and treatment of Lyme disease and associated co-infections. In particular, his studies focus on two drugs – Dapsone (diaminodiphenyl sulfone, i.e. DDS) and Pyrazinamide – to combat the persistent form of Lyme disease and co-infections. He will also explain how his Multiple Systemic Infectious Disease Syndrome (MSIDS) model and the use of these persister drugs represent new effective therapeutic options in tick-borne disorders. Dr. Horowitz will then discuss the results of his study and implications for those failing traditional therapies.

The rising numbers of individuals suffering with Lyme and other long-term disabling illnesses alert us to a needed shift in the paradigm for the diagnosis and treatment of chronic disease and consideration of a precision medical approach. To attend, please RSVP to natcaplyme@natcaplyme.org or call 703-821-8833.